Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06374173
What this trial is testing

Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hefei TG ImmunoPharma Co., Ltd. 123
Early research (Phase 1)Looking for participantsNCT07504523
What this trial is testing

Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Ying Yuan, MD 20
Early research (Phase 1)Study completedNCT00920803
What this trial is testing

A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases

Who this might be right for
Neoplasms, Colorectal
Sirtris, a GSK Company 9
Not applicableLooking for participantsNCT07451483
What this trial is testing

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Who this might be right for
Ventral HerniasCytoreductive Surgery
Jules Bordet Institute 500
Testing effectiveness (Phase 2)UnknownNCT01305980
What this trial is testing

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
SBPharmaceutical IND, Co., LTD 30
Testing effectiveness (Phase 2)Ended earlyNCT03149679
What this trial is testing

The p53 Colorectal Cancer Trial

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer Stage IVTP53 Gene Mutation
Haukeland University Hospital 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT06616259
What this trial is testing

First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study

Who this might be right for
Colorectal Cancer (CRC)CapecitabineCetuximab
Meng Qiu 452
Early research (Phase 1)Study completedNCT00497497
What this trial is testing

PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00636610
What this trial is testing

Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 199
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Testing effectiveness (Phase 2)Study completedNCT00191984
What this trial is testing

The Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Eli Lilly and Company 46
Post-approval studies (Phase 4)Study completedNCT03564938
What this trial is testing

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Who this might be right for
Metastatic Colorectal Cancer
Bayer 100
Testing effectiveness (Phase 2)Ended earlyNCT00019747
What this trial is testing

Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Institutes of Health Clinical Center (CC) 39
Testing effectiveness (Phase 2)Looking for participantsNCT04689347
What this trial is testing

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 27
Testing effectiveness (Phase 2)UnknownNCT03271255
What this trial is testing

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Who this might be right for
Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal Neoplasms+1 more
Shenzhen People's Hospital 80
Testing effectiveness (Phase 2)UnknownNCT01110785
What this trial is testing

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Leiden University Medical Center 46
Large-scale testing (Phase 3)Looking for participantsNCT04861558
What this trial is testing

Efficacy of Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Colorectal CancerPeritoneal Metastases
Uppsala University 213
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableLooking for participantsNCT01479608
What this trial is testing

Liver Transplantation and Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastasis
Oslo University Hospital 25
Testing effectiveness (Phase 2)Ended earlyNCT02204332
What this trial is testing

Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment

Who this might be right for
Colorectal Cancer
Hospital Clinico Universitario de Santiago 38
Next Page